The BalancedInvestor Club

TMO Market Analysis

Overview

Fundamentals

P/E ratio26.04Forward 19.01
EPS (TTM)$18.2011.3% YoY
Profit margin15.1%HEALTHCARE
Market cap$176.13BLarge cap

Wall Street coverage

$602.76median target· current $575.28 (+4.8%)27 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
19.01
PEG ratio
1.56
P/B
3.39
P/S (TTM)
3.90
EV/EBITDA
18.46

Profitability & growth

ROE (TTM)
13.5%
Operating margin
17.9%
Revenue growth YoY
6.2%
Dividend yield
0.4%
Beta
0.88
Last earnings
Apr 23, 2026 · Estimate $5.24 · Reported $5.44
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Thermo Fisher Scientific Inc

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.

Classification

Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
168 THIRD AVENUE, WALTHAM, MA
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$176.13B
Shares outstanding$371.6M
52W high$643.35
52W low$384.44

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer